The Latest Breaking News from Vaccine

Vaccinating pregnant women against RSV will ‘significantly’ reduce the risk their babies being hospitalised

In the Canadian town of Aylmer, where Mennonites in traditional dress walk down the main street alongside secular locals, bitter divisions over vaccine skepticism that arose during Covid have intensified with the reemergence of measles.

In today’s newsletter: With an alarming rise in cases culminating in the death of a child at Alder Hey hospital last week, urgent solutions to the disease’s resurgence are required.

New research suggests that measles infection doesn’t just make you ill in the short term; it may also undo years of immune protection

Blindness, pneumonia, severe diarrhoea and even death – measles virus infections, especially in children, can have devastating consequences. Fortunately, we have a safe and effective defence. Measles vaccines are estimated to have averted more than 60 million deaths between 2000 and 2023.

A major Danish study is the latest to confirm the benefits of routine childhood immunisations.

IN FULL

On Monday, the U.S. Food and Drug Administration (FDA) agreed to review GSK plc’s (NYSE:GSK) application to extend the indication of Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18-49 who are at increased risk.

Declining health budgets and the spread of misinformation are putting children in the UK at risk of measles, as Rebecca Thomas reports